Surrey Heartlands

Joint Formulary & PAD

Evinacumab - Homozygous familial hypercholesterolaemia

You are here : Home > Formulary Search > Evinacumab - Homozygous familial hypercholesterolaemia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

See narrative
Formulations :
  • Intravenous infusion
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
NHSE
Restrictions / Comments :
Important

NHSE Specialist Commissioned centres only.

This drug falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.

Clinicians / specialists within the Acute setting should only prescribe in line with their Trust formulary / pharmacy advice.

GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Evinacumab
Indication :
Homozygous familial hypercholesterolaemia
Group Name :
Keywords :
Brand Names Include :
Evkeeza
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Evinacumab is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Homozygous familial hypercholesterolaemia.

Committee Recommendations (0)

  • No records returned.